ConductScience.org, home

Paper831730

Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo.

Johnson RK. Biochem Pharmacol, 1977. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo. Papers, record 831730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/831730

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-asparate in vivo.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
2.82
iCite
Revised in PubMed
2019-12-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Johnson RKR K

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Aspartic AcidMajor topic
Organophosphorus CompoundsMajor topic
UridineMajor topic
Animals
Body Weight
Carbamates
Lung Neoplasms
Male
Mice
Mice, Inbred Strains
Neoplasms, Experimental
Phosphonoacetic Acid

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
7679843Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.Transplant Proc1993https://conductscience.org/library/papers/7679843PubMed
6178524Uridine rescue from the lethal toxicity of 5-fluorouracil in mice.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6178524PubMed
3815730Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3815730PubMed
3742709Comparison of the bioavailability of uridine in mice after either oral or parenteral administration.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3742709PubMed
3581416Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3581416PubMed
3396149Uridine pharmacokinetics in cancer patients.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3396149PubMed
2822596Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).Invest New Drugs1987https://conductscience.org/library/papers/2822596PubMed
2040033A phase II trial of PALA + dipyridamole in patients with advanced soft-tissue sarcoma.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/2040033PubMed
1911182Nucleoside salvage and resistance to antimetabolite anticancer agents.Br J Cancer1991https://conductscience.org/library/papers/1911182PubMed
393427m-AMSA and PALA: two new agents in cancer chemotherapy.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/393427PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/831730

GET https://conductscience.org/api/papers/v1/831730/authors